Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the morbidity of intestinal injury after open surgery and observe the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in patients undergoing laparotomy with general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nanfang Hospital of Southern Medical University
• Treatments: Anesthetics; Dexmedetomidine

Criteria

Inclusion Criteria:

• Aged between 18 and 70 years;

• Elective abdominal surgery under general anesthesia, operation time > 2h;

• ASA Ⅰ ~ Ⅲ;

• Patient informed and consent to accept the test.

Exclusion Criteria:

• persons under the age of 18 or over 70 years old;

• pregnant or lactating women;

• combined with lung, liver, kidney, cardiovascular and hematopoietic system disease and other serious primary disease;

• preoperative Hb <7g / l;

• oral sulfa drugs or nicorandil antihypertensive drugs;

• lower extremity amputees;

• with peripheral vascular disease;

• patients with mental illness or severe neurosis;

• can not express the subjective symptoms;

• nearly 3 months to participate in other drug clinical trials;

• within 3 months of receiving other surgical treatment.